1 Table of Contents2 Introduction
2.1 What Is This Report About?
2.2 Intraocular Lens (IOL) Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Intraocular Lens (IOL) Market, United States
3.1 Intraocular Lens (IOL) Market, United States, Revenue ($m), 2018-2033
3.1.1 Foldable IOL Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Intraocular Lens (IOL) Market, United States, Volume (Units), 2018-2033
3.2.1 Foldable IOL Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Intraocular Lens (IOL) Market, United States, Average Price ($) , 2018-2033
3.4 Intraocular Lens (IOL) Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Intraocular Lens (IOL) Market
4.1 Alcon Inc
4.1.1 Company Overview
4.2 Johnson & Johnson Vision Care Inc
4.2.1 Company Overview
4.3 Bausch & Lomb Inc
4.3.1 Company Overview
4.4 Carl Zeiss Meditec AG
4.4.1 Company Overview
4.5 Hoya Corp
4.5.1 Company Overview
4.6 STAAR Surgical Co
4.6.1 Company Overview
6 Recent Developments
6.1 Corporate Communications
6.1.1 Nov 07, 2025: STAAR Surgical Amends Alcon Merger Agreement
6.1.2 Oct 16, 2025: STAAR Surgical Confirms No Acquisition Proposals Other Than Alcon
6.1.3 Oct 10, 2025: Broadwood Partners Issues Letter To STAAR Surgical’s Board Questioning Its Diligence In Rush To Reaffirm Support For Alcon Sale
6.1.4 Oct 09, 2025: Abbott And Abbott Fund Support Northern Illinois Food Bank With $250,000 Grant To Address Childhood Hunger
6.1.5 Sep 16, 2025: STAAR Surgical Board Confirms Alcon Merger as Best Value for Stockholders
6.1.6 Sep 02, 2025: Jennifer Kang-Mieler Named Director of the Semcer Center for Healthcare Innovation
6.2 Financial Announcements
6.2.1 Feb 11, 2025: STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results
6.2.2 Jan 22, 2025: Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2024 Financial Results on February
6.2.3 Jan 13, 2025: STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025
6.3 Government and Public Interest
6.3.1 Aug 14, 2025: RxSight to Present at the Wells Fargo Healthcare Conference
6.3.2 Nov 25, 2024: STAAR Surgical to Participate in BTIG Ophthalmology Day
6.4 Legal And Regulatory
6.4.1 Sep 22, 2025: Yunqi Capital, 5.1% Holder of STAAR Surgical, Announces Opposition to Sale to Alcon
6.5 Other Significant Developments
6.5.1 Sep 22, 2025: Yunqi Capital, 5.1% Holder of STAAR Surgical, Announces Opposition to Sale to Alcon
6.5.2 May 29, 2025: Addtronics Strengthens Medical Device Automation Capabilities with Addition of DAC International
6.6 Product News
6.6.1 Nov 10, 2025: SpyGlass Pharma Reports Positive Results from BIM-IOL System Trials
6.6.2 Oct 30, 2025: Revolutionary Cataract Surgery Technology Transforms Eye Care with Precision and Enhanced Patient Outcomes
6.6.3 Oct 17, 2025: Lumetrics Wavefront Sensors
6.6.4 Oct 14, 2025: SpyGlass Pharma’s BIM-IOL System Shows Significant IOP Reduction at 24 Months
6.6.5 Oct 14, 2025: BVI’s Finevision HP Receives FDA Approval for Advanced Trifocal IOLs
6.6.6 Oct 13, 2025: Johnson & Johnson Celebrates Milestone of 100K TECNIS ODYSSEY IOLs Implanted at the 2025 American Academy of Ophthalmology Annual Meeting
6.6.7 Oct 06, 2025: Samsara Vision Announces First Pseudophakic Surgery in the PERSPECTIVE Clinical Trial
6.6.8 Sep 26, 2025: STAAR Surgical Publishes Presentation Highlighting Compelling, Certain Cash Value Offered by Alcon Merger and Meaningful Downside Risks if Alcon Merger Is Not Approved
6.6.9 Sep 11, 2025: K8 Implant From Inflammasome Therapeutics Reduces Lesion Growth in Geographic Atrophy
6.6.10 Apr 23, 2025: EyeCare Partners Presents Latest Innovations in Eye Care at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 in Los Angeles
6.7 Strategy And Business Planning
6.7.1 Sep 02, 2025: Jennifer Kang-Mieler Named Director of the Semcer Center for Healthcare Innovation
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 the analyst Consulting
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
Table 1: Intraocular Lens (IOL) Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Foldable IOL Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Intraocular Lens (IOL) Market, United States, Volume (Units), 2018-2033
Table 4: Foldable IOL Market, United States, Volume (Units), 2018-2033
Table 5: Intraocular Lens (IOL) Market, United States, Average Price ($), 2018-2033
Table 6: Intraocular Lens (IOL) Market, United States, Company Share by Revenue ($m), 2024
Table 7: Intraocular Lens (IOL) Market Pipeline Products
Table 8: Total Number of Primary Research Participants, Ophthalmic Devices Market, by Country
List of Figures
Figure 1: Intraocular Lens (IOL) Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Foldable IOL Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Intraocular Lens (IOL) Market, United States, Volume (Units), 2018-2033
Figure 4: Foldable IOL Market, United States, Volume (Units), 2018-2033
Figure 5: Intraocular Lens (IOL) Market, United States, Company Share (%), 2024
